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PURPOSE: To study, through endoscopy, the postoperative structural changes of the intranasal ostium following external
dacryocystorhinostomy and to evaluate the influence of saline solution and 5-fluorouracil.
METHODS: Fifty patients were distributed into the following groups: Group SS—dacryocystorhinostomy and an injection of
saline solution during surgery (13 patients); Group 5-FU1—dacryocystorhinostomy and an injection of 5 fluorouracil during
surgery (17 patients); Group C—dacryocystorhinostomy only (11 patients); Group 5-FU3—dacryocystorhinostomy and 3 injections,
1 during surgery and 1 on the third and fifth postsurgical days (9 patients).
RESULTS: Pair-wise group comparisons using the nonparametric Mann-Whitney test revealed that there was a significant reduction
of the ostium area only in Group 5-FU1 vs. Group SS on the 60th postoperative day (P <.01); however, a comparative study among
the 4 groups using the Kruskal-Wallis test showed no significant changes in the ostium area on the 60th postoperative day. The
ostium area within groups at the 30th vs 60th postoperative day was significantly reduced for Group C (P < .05; Mann-Whitney
test); no significant changes were found for the other groups.
DISCUSSION: These results suggest that the use of 5-fluorouracil in external dacryocystorhinostomy does not significantly
influence the final size of the surgical fistula as determined 2 months postsurgery.
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INTRODUCTION
Dacryocystorhinostomy is a surgical technique in which
an anastomosis is made between the lacrimal sac and the
nasal cavity. It is indicated for most of chronic
dacryocistitis. The percentage of success with dacryo-
cystorhinostomy presented by several authors is usually
greater than 90%, regardless of the surgical technique
used.1,2
In spite of technical advances, recurrences may occur
within 4 to 6 weeks after surgery.3 Anatomic conditions and
affections that may lead to lack of success include a small
lacrimal sac and ethmoid cells in the bone trepanation area,4
Paget’s disease,5 sarcoidosis,6 nasal fracture, medium tur-
binate hypertrophy, septal deviation, and nasal cavity syn-
echia.7
The most frequent postoperative conditions associated
with recurrences are obstruction of the intranasal ostium
by healing or granulation tissue, nasal cavity synechia,8 in-
adequate size and position of the osteotomy,9 mucosa flap
fall,7 and incomplete lacrimal sac opening.10
In dacryocystorhinostomy, several materials, such as a
polyethylene tubing,11 silicone sponge,12 silicone tubing,2
and absorbable gelatin sponge,13 have been used in the anas-
tomosis to prevent ostium obstruction by healing or granu-
lation tissue.
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At the time of writing, antimetabolites are frequently
used when treating a number of ocular pathologies char-
acterized by the proliferation of non-neoplastic cells; 5-
fluorouracil (5-FU) is one of such drugs, because it has a
powerful inhibitory effect on mitosis. Responses are gen-
erally good when compared to other antimetabolites and
5-FU has been shown to have a powerful inhibitory effect
on growing fibroblasts.14
The Fluorouracil Filtering Surgery Study Group (FFSS),
formed in the United States in 1989, evaluated the results
of trabeculectomy with the use of subconjunctival 5-FU. Sub-
conjunctival 5-FU injections were recommended after
trabeculectomy in patients with uncontrolled glaucoma with
poor prognosis, especially with aphakic glaucoma, and in
patients with previous surgical failure.15 The FFSS concluded
after 5 years of follow-up that 5-FU greatly improves the
surgical prognosis of trabeculectomy.16 Use of 5-FU is a safe
and effective method by which a significant number of fail-
ing filtration blebs can be rescued from failure.17
This study aimed at studying, through endoscopy the
postoperative structural changes of the intranasal ostium
that take place following external dacryocystorhinostomy,
as well as to evaluate the influence of the use of saline so-
lution versus 5-FU on the evolution of the ostium, seeking
a complementary alternative for the treatment of dacryo-
cystitis with a poor prognosis.
MATERIALS AND METHODS
Patients with dacryocystitis were selected from the Oph-
thalmology Clinic of the State University of Campinas
Clinic Hospital (Brazil). The hospital’s Ethics Commission
approved the research protocol.
Ophthalmologic, clinical, laboratory, and nasal endos-
copy exams were performed for all the patients before the
surgery. Patients with nasal affections, such as severe sep-
tal deviation, turbinate hypertrophy, nasal fractures, and
other lacrimal system problems, were excluded from the
study.
Fifty patients underwent external dacryocystorhinostomy
associated with the use or not of 5-FU. We adopted the sur-
gical technique that uses only 2 anterior flaps from the lac-
rimal sac mucosa and the nasal mucosa, respectively. We
standardized the size of the osteotomy at 10 mm for all the
patients. The suture of the mucosa flaps was done with vycryl
5-0, and the stitches were placed at an adjacent subcutane-
ous tissue level to prevent the flaps from falling.
Patients were randomly distributed into 4 groups as fol-
lows: Group SS— dacryocystorhinostomy and an injection
of saline solution during the surgery (13 patients); Group
5-FU1—dacryocystorhinostomy and an injection of 5-FU
during the surgery (17 patients); Group C—dacryocystorhi-
nostomy only (11 patients); Group 5-FU3—dacryocystorhi-
nostomy and 3 injections of 5-FU, 1 injection during sur-
gery and 1 on the third and fifth postoperative days (9 pa-
tients).
Preparation of the solution for Group 5-FU1 prior to the
surgery was as follows: 1 mL of 5-FU (250 mg/10 mL) was
added to 4 mL of 0.9% saline solution; 0.50 mL (2.5 mg)
of this solution was injected into the nasal mucosa at the
end of the surgery. The saline solution used in this prepa-
ration was also used for Group SS. At the end of the surgi-
cal procedure, 0.50 mL of the appropriate solution was in-
jected into the nasal mucosa beside the inferior edge of the
ostium with an insulin syringe and needle.
The solution for Group 5-FU3 was prepared as follows:
4 mL of 5-FU (250 mg/10 mL) was added to 6 mL of 0.9%
saline solution, and 0.50 mL (5 mg) was injected as previ-
ously described into the nasal mucosa at the end of sur-
gery. The same dose was repeated in the third and fifth post-
operative days. For those postoperative treatments, 10%
Xylocaine spray was administered as the topical anesthetic,
and subsequently, the 5-FU solution was injected into the
nasal mucosa using a 30-gauge needle and an insulin sy-
ringe into the same area where it had been injected during
the surgical procedure. The total dose used over the 3 in-
jections was 15 mg.
The patients were examined on the 7th, 30th, and 60th
postoperative days, when they underwent ophthalmologic,
probe, and irrigation exams of the lacrimal system, as well
as endoscopic evaluation of the surgical area of the nasal
cavity. We performed vertical and horizontal measurement
of the ostium with an L measurer divided into millimeters
on one side (Figure 1). A rigid Hopkins telescope of 4 mm
diameter and with a 30° optical axis (Storz model) was
used, which allowed clear viewing of the nasal cavity. En-
doscopy was performed on the patients in the dorsal decu-
bitus position after topical anesthesia with nasal packing
Figure 1 - Surgical ostium - measurement of the vertical diameter with a L
measurer
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soaked in 2.5% neotutocaine solution with 1/1000 adrena-
line. In order to evaluate the dimensions of the surgical os-
tium, an approximate calculation of the area was performed
based on the predominant shape found at endoscopy. The
determination of the area was based on the formula for the
calculation of an elliptic area: A = r/4 x V x H, using the
measurement of 2 opposed diameters of the ostium (Fig-
ure 1). By convention, the horizontal diameter (H) was the
one parallel to the lacrimal sac, and the vertical diameter
(V) was the one perpendicular to the first one.
The ostium area on the 60th postoperative day was com-
pared among the 4 groups using the nonparametric Kruskal-
Wallis test. Pair-wise comparisons between groups regard-
ing the area of the ostium on the 60th postoperative day
were using the nonparametric Mann-Whitney test. Within-
group changes at the 30th vs 60th postoperative day were
tested with the nonparametric Mann-Whitney test. A P
value less than .05 was taken to indicate a significant dif-
ference.
RESULTS
Endoscopic evaluation
The incidence of nasal mucosa flap fall was as follows:
1 case (7.7%) in Group SS, 10 cases (59%) in Group 5-
FU1, 3 cases (27%) in Group C, and 5 cases (56%) in
Group 5-FU3. In none of the cases was there a fall of the
entire flap with occlusion of the surgical ostium.
An oval ostium shape predominated in all the groups
as follows: 10 cases (77%) in Group SS, 8 cases (47%) in
Group 5-FU1, 10 cases (91%) in Group C, and 5 cases
(56%) in Group 5-FU3. The remaining cases presented a
round ostium shape.
The comparative study between the 4 groups using the
Kruskal-Wallis test did not show significant changes on the
60th postoperative day; however, the pair-wise comparisons
revealed that the ostium area of Group SS was significantly
larger than that of Group 5-FU1 (P < .01, Mann-Whitney
test) (Figure 2).
Regarding changes in the ostium area between the 30th
and the 60th days, an increase of the ostium area occurred
in 3 cases (23%) in Group SS (SS), 5 cases (29%) in Group
5-FU1,1 case (9.1%) in Group C, and 3 cases (33%) in
Group 5-FU3. A decrease in the ostium area was observed
in 4 cases (31%) in Group SS, 9 cases (53%) Group 5-FU1,
1 case (9.1%) in Group C, and 3 cases (33%) in Group 5-
FU3; There was no change in the ostium area for 12 cases
as follows: 6 cases (46%) in Group SS, 3 cases (18%) in
Group 5-FU1, 1 case (9.1%) in Group C, and 2 cases (22%)
in Group 5-FU3. The change in area from the 30th to the
60th postoperative day was significantly reduced only in
Group C (P < .05, Mann-Whitney test) (Figure 3). No other
significant differences were found regarding this parameter.
Granulation tissue was present at the intranasal ostium
level in all the groups as follows: 6 cases (46%), 10 cases
(59%), 3 cases (27%), and 3 cases (33%) in Groups SS, 5-
FU1, C, and 5-FU3, respectively. Extraction of the granu-
lation tissue was performed only in symptomatic patients
with an ostium blockage that impeded lacrimal drainage
as follows: 3 cases in Group SS, 4 cases in Group 5-FU1,
and 1 case in Group 5-FU3. In all of theses cases there was
epiphora and disappearance of secretion.
Persistent epiphora was observed in 4 patients. The en-
doscopic evaluation in the first week showed the presence
of a bone fragment in the surgical fistula in 1 of these cases
(Group C), which was removed on the same occasion. In
another symptomatic patient, a patent lacrimal system was
Figure 2 - The graph shows the postoperative intranasal ostium areas by
treatment group on the 60th postoperative day
Figure 3 - The graph describes the ostium area at the 30th vs 60th postoperative
day, by treatment group
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observed. We suspected that the lacrimation was due to a
maxillary sinusitis, since the endoscopy showed the pres-
ence of secretion from the main ostium of the maxillary
sinus. In the other 2 cases, we observed a concentric in-
crease of healing tissue that greatly decreased the size of
the ostium in one of the patients (Group 5-FU1), and com-
pletely occluded it in the other (Group 5-FU3).
Comparing the number of flap falls among the several
groups (Figure 4), there were no significant differences dur-
ing the observation period. When the data was reorganized
into 3 categories (saline solution, control, and 5-FU; Fig-
ure 5), there were significantly more flap falls in the 5-FU
group compared to saline solution group (Group SS)
(Mann-Whitney test, P < .01).
There was no significant difference concerning the oc-
currence of granulation tissue among the groups (P = .361).
Among the 50 patients who underwent dacryocystorhi-
nostomy, only 1 experienced a total ostium occlusion by
the healing tissue, and there was persistent epiphora in 2
others. The presence of ostium with a much-reduced area
was observed for these last cases.
No nasal, ocular, or systemic complications from the
use of 5-FU were observed in this study.
DISCUSSION
In this study, the size of the final surgical ostium was
always smaller than the initial surgical orifice. This result
is similar to that of Linberg et al,18 who showed that an
ample osteotomy did not necessarily result in a larger in-
tranasal ostium. Those authors attributed the reduction of
the ostium area to the contracture of the wound during the
healing process. Although in the present study the size of
the osteotomy was the same in all the patients, there was
great variation of the ultimate intranasal ostium among the
subjects of the same group, suggesting the presence of sev-
eral factors that could influence the final result.
The distinct decrease in the healed intranasal ostium
area when compared to the surgical opening is not surpris-
ing, considering normal healing processes. Ross19 described
the stages of the healing process as follows: hemostasis,
inflammation, and remodeling. The healing contracture
takes place during the last stage of the process.
If the size of the final ostium is related to the healing
process, it is valid to assume that the use of a drug that
inhibits fibroblast proliferation would result in a larger os-
tium area. The option to use 5-FU was based on the fact
that these antimetabolites have produced positive results in
ocular surgeries, when the main objective is to interfere
with the healing process.
A single dose of 5-FU has been shown to be effective
in the treatment of massive periretinal proliferation, as is
shown in the experimental work of Blumenkrans et al.20
This antimetabolite has also been used to improve surgi-
cal prognosis in the eyes of human patients with glau-
coma.15 Until 1989, most researchers used a 105-mg dose
in patients with high-risk glaucoma; later, reduced dosages
were used, producing similar results with much fewer side
effects.21;22 The occurrence of a flap fall in the 5-FU groups
occurred regardless of the dosage and the frequency of dos-
ing. Flap falls have been cited as the cause of recurrence,
as they block the surgical ostium.7 Endoscopy showed that
the flap could partially return to the nasal mucosa plane.
A complete flap fall was not present in any of the cases.
Kao et al23 observed that the ostium area was signifi-
Figure 4 - Percentage of flap falls on 7th, 30th, and 60th days after surgery, by
4 groups (C, SS, 5-FU1, and 5-FU3)
Figure 5 - Percentage of flap falls on 7th, 30th, and 60th postoperative day, by
3 groups (C, SS, and 5-FU
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cantly reduced in patients in whom only endonasal dacryo-
cystorhinostomy was performed, compared to those that
also received an intrasurgical injection of mitomycin. The
authors concluded that this was due to the use of the an-
timetabolite. The evaluation via helical computed tomo-
graphic dacryocystography of the effect of intrasurgical
mitomycin in patients undergoing external dacryocystorhi-
nostomy revealed that the use of this antimetabolite resulted
in larger ostium areas.24 In contrast, in the present study,
the results obtained at the 60-day follow-up evaluation re-
vealed that the ostium area was distinctly larger in patients
receiving a saline solution injection than in patients receiv-
ing an 5-FU injection. Additionally, the number of flap falls
of the nasal mucosa was less frequent in patients receiv-
ing a saline injection compared to those receiving 5-FU in-
jections.
Group C (control group) presented the natural evolu-
tion of the ostium using the technique of 2 anterior flaps,
characterized by the consistent occurrence of a distinct de-
crease in area of the surgical ostium as well as the occur-
rence of flap falls. Since all possible determinant causes
of the flap fall, such as the use of quickly absorbing thread
and inadequate fixation of sutures, were avoided, the most
probable causes of this occurrence were the growing and
thickening of the healing tissue or the partial return of the
nasal mucosa to its original position.
The number of nasal mucosa flap falls was significantly
greater in the groups receiving 5-FU injections compared
to the group receiving a saline solution injection. The pro-
portion of flap falls in the Group C was smaller than that
in the 5-FU groups and larger than that in Group SS; how-
ever, this variation was not statistically significant.
The within-group evaluation showed that the decrease
in the area between the 30th and 60th postoperative days was
statistically significant only in Group C. This finding indi-
cates that the smaller decrease in area could be the influ-
ence of the mechanical factor of the injection, rather than
the effect of 5-FU.
In the present study, the endoscopic evaluation revealed
that the occurrence of epiphora was not related to the os-
tium size.
We can assume that in the 2 symptomatic cases in
which the lacrimal pathway was patent, a much reduced
ostium area could have hindered the proper lacrimal drain-
age in these patients. The persistence of a bone fragment
in the surgical area and the presence of ethmoid cells in
the osteotomy area that were observed in these cases could
have caused the healing exacerbation, significantly decreas-
ing the ostium. In the only case where there was complete
surgical ostium occlusion, the presence of ethmoid cells
during the surgery was verified. According to Picó,4 eth-
moid cells constitute anatomic variations that predispose
surgical failure.
Endoscopy was crucial for clearing up persistent epi-
phora, providing information for correct diagnosis and treat-
ment. Good results were obtained with the removal of
granulation tissue or hematic crust that was blocking the
central ostium area.
According to Piaton et al25 and Bakri et al,26 the use of
5-FU in patients undergoing laser dacryocystorhinostomy
did not improve the surgical prognosis compared to the re-
sults obtained with patients who underwent only the sur-
gical treatment. Accordingly, the results of this study indi-
cate that the use of 5-FU in external dacryocystorhinostomy
is also without a significant influence in the final size of
the surgical fistula at the 60 days postsurgery.
RESUMO
Costa MN, Marcondes AM, Sakano E, Kara-José N. Estu-
do endoscópico do óstio intranasal no pós-operatório de
dacriocistorrinostomia externa e influência do uso de so-
lução salina e de 5 fluorouracil. Clinics. 2007;62(1):41-6.
OBJETIVO: Estudar, através da endoscopia, as alterações
estruturais pós-operatórias do óstio intranasal na dacriocis-
torrinostomia externa, e avaliar a influência da solução sa-
lina e do 5 fluorouracil.
MÉTODOS: Cinquenta pacientes foram distribuídos nos
seguintes grupos: Grupo SS– 13 pacientes submeteram-se
à dacriocistorrinostomia com uso de solução salina; Gru-
po 5-FU1- 17 pacientes submeteram-se à dacriocistor-
rinostomia e injeção de 5 fluorouracil; Group C—11 paci-
entes submeteram-se apenas à dacriocistorrinostomia; Gru-
po 5-FU3- 9 pacientes submeteram-se à dacriocistor-
rinostomia associada a três injeções de 5 fluorouracil.
RESULTADOS: A comparação pareada pelo teste não
paramétrico de Mann-Whitney revelou redução significa-
tiva da área do óstio apenas na comparação Grupo 5-FU1
vs. Grupo SS, no 60º dia após a cirurgia (P <.01). No en-
tanto, um estudo comparativo entre os 4 grupos usando o
teste de Kruskal-Wallis não revelou diferenças significati-
vas na área do óstio no 60º dia após a cirurgia. Na compa-
ração intra-grupos, a área do óstio no 30 º vs 60 º dia após
a cirurgia mostrou redução significativa para o Grupo C
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(P < .05; teeste de Mann-Whitney); nenhuma outra com-
paração apresentou diferenças significativas.
DISCUSSÃO: O resultado deste estudo sugere que o uso
de 5 fluorouracil na dacriocistorrinostomia externa não in-
fluencia significantemente no tamanho final da fístula ci-
rúrgica durante os dois meses de avaliação.
UNITERMOS: Fluorouracil. Dacriocistorrinostomia.
Endoscopia. Dacriocistite.
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